{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:06:21Z","timestamp":1795061181144,"version":"4.10.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The cumulative economic burden of rare diseases surpasses that of common conditions, yet patterns of healthcare resource utilization (HRU) across rare diseases remain poorly characterized. This study leverages multimodal data collected during clinical care and through surveys to provide an in-depth evaluation of HRU across the disease journey of individuals with rare genetic diseases. Individuals with a confirmed diagnosis of Kleefstra syndrome (KS; n\u2009=\u200940) or SLC6A1 epileptic encephalopathy (SLC6A1; n\u2009=\u200930) were recruited. Structured and unstructured data were abstracted from participants\u2019 medical records. Encounters per person-year of follow-up were calculated and compared pre- and post-diagnosis. Parents\/guardians completed surveys assessing the impact of the participant\u2019s diagnosis on their care.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Records were available for a median of 6.4\u00a0years of follow-up from 268 unique healthcare facilities (median per patient\u2009=\u20094.5 facilities). Numbers of healthcare encounters were not significantly different 1\u00a0year pre- and post-diagnosis for either condition; however, the proportion of specialty encounters pre- and post-diagnosis varied significantly. Genetics encounters decreased for both conditions post-diagnosis. Cardiology, sleep medicine, and radiology encounters increased in KS post-diagnosis; conversely, audiology encounters decreased in KS post-diagnosis, and radiology encounters decreased in SLC6A1 post-diagnosis. Among specialty encounter types assessed, general practitioner (e.g. primary care, including pediatrics) encounters were the most common type for KS participants and the second-most common for SLC6A1 participants (after neurology encounters) both 1\u00a0year pre- and post-diagnosis. The number of both echocardiograms and electrocardiograms (ECG) significantly increased in KS 1\u00a0year post-diagnosis. 68% of survey respondents indicated that the participant\u2019s care changed post-diagnosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Though there was no significant difference in the number of encounters pre- and post-diagnosis, significant changes in types of HRU suggest that diagnosis leads to more appropriate care and treatment. Advocacy organizations, researchers, drug developers, payors, and policymakers should consider the value of an early diagnosis to improve long-term outcomes and quality of life for patients and invest in measures that will shorten the time to diagnosis accordingly.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03879-x","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T09:07:12Z","timestamp":1751879232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Characterizing healthcare resource utilization in two rare diseases (Kleefstra syndrome and SLC6A1 epileptic encephalopathy) using multimodal real-world data"],"prefix":"10.1186","volume":"20","author":[{"given":"Caitlin A.","family":"Nichols","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Nysetvold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainslie","family":"Tisdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Cutillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley N.","family":"Cogell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson D.","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5856-4197","authenticated-orcid":false,"given":"Kristina","family":"Cotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"3879_CR1","unstructured":"Facts & Stats about Rare Disease [Internet]. Global Genes. 2016. https:\/\/globalgenes.org\/wp-content\/uploads\/2015\/12\/2016-WRDD-Fact-Sheet.pdf"},{"key":"3879_CR2","unstructured":"Rare Disease Facts [Internet]. Global Genes. https:\/\/globalgenes.org\/rare-disease-facts\/"},{"issue":"9629","key":"3879_CR3","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/S0140-6736(08)60872-7","volume":"371","author":"A Schieppati","year":"2008","unstructured":"Schieppati A, Henter JI, Daina E, Aperia A. Why rare diseases are an important medical and social issue. The Lancet. 2008;371(9629):2039\u201341.","journal-title":"The Lancet"},{"issue":"1","key":"3879_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13023-022-02299-5","volume":"17","author":"G Yang","year":"2022","unstructured":"Yang G, Cintina I, Pariser A, Oehrlein E, Sullivan J, Kennedy A. The national economic burden of rare disease in the United States in 2019. Orphanet J Rare Dis. 2022;17(1):163.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"3879_CR5","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1038\/s41436-021-01241-7","volume":"23","author":"AA Navarrete-Opazo","year":"2021","unstructured":"Navarrete-Opazo AA, Singh M, Tisdale A, Cutillo CM, Garrison SR. Can you hear us now? The impact of health-care utilization by rare disease patients in the United States. Genet Med. 2021;23(11):2194\u2013201.","journal-title":"Genet Med"},{"issue":"11","key":"3879_CR6","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.3390\/ijerph18115705","volume":"18","author":"YH Chen","year":"2021","unstructured":"Chen YH, Lai YC, Wu YC, Sasaki J, Tsai KT, Ho CH. Healthcare utilization in different stages among patients with dementia: a nationwide population-based study. Int J Environ Res Public Health. 2021;18(11):5705.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"3879_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.fertnstert.2014.10.011","volume":"103","author":"M Fuldeore","year":"2015","unstructured":"Fuldeore M, Yang H, Du Xiaoyan E, Soliman AM, Wu EQ, Winkel C. Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases. Fertil Steril. 2015;103(1):163\u201371.","journal-title":"Fertil Steril"},{"issue":"8","key":"3879_CR8","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1111\/jgs.14227","volume":"64","author":"PJ Lin","year":"2016","unstructured":"Lin PJ, Zhong Y, Fillit HM, Chen E, Neumann PJ. Medicare expenditures of individuals with Alzheimer\u2019s disease and related dementias or mild cognitive impairment before and after diagnosis. J Am Geriatr Soc. 2016;64(8):1549\u201357.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"3879_CR9","doi-asserted-by":"publisher","first-page":"e41308","DOI":"10.1371\/journal.pone.0041308","volume":"7","author":"M Violato","year":"2012","unstructured":"Violato M, Gray A, Papanicolas I, Ouellet M. Resource use and costs associated with coeliac disease before and after diagnosis in 3,646 cases: results of a UK primary care database analysis. PLoS ONE. 2012;7(7):e41308.","journal-title":"PLoS ONE"},{"issue":"1","key":"3879_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1055\/s-0040-1718518","volume":"52","author":"K \u010cesk\u00e1","year":"2021","unstructured":"\u010cesk\u00e1 K, \u010cesk\u00fd L, O\u0161lej\u0161kov\u00e1 H, Aulick\u00e1 \u0160. The direct costs of Dravet\u2019s syndrome before and after diagnosis assessment. Neuropediatrics. 2021;52(1):6\u201311.","journal-title":"Neuropediatrics"},{"key":"3879_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2147\/JAA.S354062","volume":"15","author":"F Hardtstock","year":"2022","unstructured":"Hardtstock F, Krieger J, Wilke T, Lukas M, Ultsch B, Welte R, et al. Use of biologic therapies in the treatment of asthma\u2013a comparative real world data analysis on healthcare resource utilization and costs before and after therapy initiation. J Asthma Allergy. 2022;15:407\u201318.","journal-title":"J Asthma Allergy."},{"key":"3879_CR12","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2147\/COPD.S342244","volume":"17","author":"A Gabrio","year":"2022","unstructured":"Gabrio A, Gunsoy NB, Baio G, Martin A, Paly VF, Risebrough N, et al. Single-inhaler triple therapy in patients with advanced copd: bayesian modeling of the healthcare resource utilization data and associated costs from the IMPACT trial. Int J Chron Obstruct Pulmon Dis. 2022;17:1633\u201342.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"3879_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-02061-3","author":"A Tisdale","year":"2021","unstructured":"Tisdale A, Cutillo CM, Ramaa N, Russo P, Laraway B, Haendel M, et al. The IDeaS initiative: pilot study to assess the impact of rare diseases on patients and healthcare systems. Orphanet J Rare Dis. 2021. https:\/\/doi.org\/10.1186\/s13023-021-02061-3.","journal-title":"Orphanet J Rare Dis"},{"key":"3879_CR14","first-page":"564","volume":"2014","author":"KW Fung","year":"2014","unstructured":"Fung KW, Richesson R, Bodenreider O. Coverage of rare disease names in standard terminologies and implications for patients, providers, and research. AMIA. 2014;2014:564.","journal-title":"AMIA"},{"key":"3879_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-021-01763-y","volume":"16","author":"J Rico","year":"2021","unstructured":"Rico J, de Garibay Echevarria-Gonzalez LJ, Garcia-Lopez M, Guardiola-Vilarroig S, Maceda-Roldan LA, Zurriaga O, et al. The interoperability between the Spanish version of the international classification of diseases and ORPHAcodes: towards better identification of rare diseases. Orphanet J Rare Dis. 2021;16:1\u20133.","journal-title":"Orphanet J Rare Dis"},{"key":"3879_CR16","doi-asserted-by":"crossref","unstructured":"Goodman SJ, Cytrynbaum C, Chung BHY, Chater-Diehl E, Aziz C, Turinsky AL, et al. EHMT1 pathogenic variants and 9q34.3 microdeletions share altered DNA methylation patterns in patients with Kleefstra syndrome. J Transl Genet Genomics [Internet]. 2020. https:\/\/jtggjournal.com\/article\/view\/3507","DOI":"10.20517\/jtgg.2020.23"},{"key":"3879_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21523","author":"WM Nillesen","year":"2011","unstructured":"Nillesen WM, Yntema HG, Moscarda M, Verbeek NE, Wilson LC, Cowan F, et al. Characterization of a novel transcript of the EHMT1 gene reveals important diagnostic implications for Kleefstra syndrome. Hum Mutat Var Inform Dis. 2011. https:\/\/doi.org\/10.1002\/humu.21523.","journal-title":"Hum Mutat Var Inform Dis."},{"issue":"4","key":"3879_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/jmg.2004.028464","volume":"42","author":"T Kleefstra","year":"2005","unstructured":"Kleefstra T. Disruption of the gene euchromatin histone methyl transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome. J Med Genet. 2005;42(4):299\u2013306.","journal-title":"J Med Genet"},{"issue":"5","key":"3879_CR19","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ajhg.2015.02.016","volume":"96","author":"GL Carvill","year":"2015","unstructured":"Carvill GL, McMahon JM, Schneider A, Zemel M, Myers CT, Saykally J, et al. Mutations in the GABA transporter SLC6A1 cause epilepsy with myoclonic-atonic seizures. Am J Hum Genet. 2015;96(5):808\u201315.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"3879_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/(SICI)1096-9861(19980622)396:1<51::AID-CNE5>3.0.CO;2-H","volume":"396","author":"F Conti","year":"1998","unstructured":"Conti F, Melone M, De Biasi S, Minelli A, Brecha NC, Ducati A. Neuronal and glial localization of GAT-1, A high-affinity?-aminobutyric acid plasma membrane transporter, in human cerebral cortex: with a note on its distribution in monkey cortex. J Comp Neurol. 1998;396(1):51\u201363.","journal-title":"J Comp Neurol"},{"key":"3879_CR21","unstructured":"Kleefstra T, de Leeuw N. Kleefstra Syndrome. Gene Reviews. 2010. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK47079\/"},{"issue":"4","key":"3879_CR22","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/brain\/awaa051","volume":"143","author":"JA L\u00f3pez-Rivera","year":"2020","unstructured":"L\u00f3pez-Rivera JA, P\u00e9rez-Palma E, Symonds J, Lindy AS, McKnight DA, Leu C, et al. A catalogue of new incidence estimates of monogenic neurodevelopmental disorders caused by de novo variants. Brain. 2020;143(4):1099\u2013105.","journal-title":"Brain"},{"key":"3879_CR23","unstructured":"Goodspeed K, Demarest S, Johannesen K, Kang J, Lal D, Angione K. SLC6A1-Related Neurodevelopmental Disorder. GeneReviews. 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK589173\/"},{"issue":"2","key":"3879_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/braincomms\/fcaa170","volume":"2","author":"K Goodspeed","year":"2020","unstructured":"Goodspeed K, Perez-Palma E, Iqbal S, Cooper D, Scimemi A, Johannesen KM, et al. Current knowledge of SLC6A1-related neurodevelopmental disorders. Brain Commun. 2020;2(2):170.","journal-title":"Brain Commun."},{"key":"3879_CR25","unstructured":"AllStripes Research [Internet]. [cited 2023 Jan 24]. Kleefstra syndrome research program | AllStripes. https:\/\/www.allstripes.com\/program\/kleefstra"},{"key":"3879_CR26","unstructured":"AllStripes Research [Internet]. [cited 2023 Jan 24]. SLC6A1 research program | AllStripes. https:\/\/www.allstripes.com\/program\/slc6a1"},{"issue":"8","key":"3879_CR27","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1136\/thoraxjnl-2017-210394","volume":"73","author":"L Bessonova","year":"2018","unstructured":"Bessonova L, Volkova N, Higgins M, Bengtsson L, Tian S, Simard C, et al. Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor. Thorax. 2018;73(8):731\u201340.","journal-title":"Thorax"},{"key":"3879_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.24203","author":"S Al-Zaidy","year":"2018","unstructured":"Al-Zaidy S, Pickard AS, Kotha K, Alfano LN, Lowes L, Paul G, et al. Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy. Pediatr Pulmonol. 2018. https:\/\/doi.org\/10.1002\/ppul.24203.","journal-title":"Pediatr Pulmonol"},{"key":"3879_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-017-0622-4","volume":"12","author":"Y Zurynski","year":"2017","unstructured":"Zurynski Y, Deverell M, Dalkeith T, Johnson S, Christodoulou J, Leonard H, et al. Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays. Orphanet J Rare Dis. 2017;12:1\u20139.","journal-title":"Orphanet J Rare Dis"},{"key":"3879_CR30","unstructured":"Kole A, Faurisson F, Mavris M. The Voice of 12,000 Patients. 324 p. https:\/\/www.eurordis.org\/publications\/the-voice-of-12000-patients\/"},{"issue":"2","key":"3879_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.dhjo.2020.101018","volume":"14","author":"A Haseley","year":"2021","unstructured":"Haseley A, Wallis K, DeBrosse S. Kleefstra syndrome: impact on parents. Disabil Health J. 2021;14(2): 101018.","journal-title":"Disabil Health J"},{"key":"3879_CR32","unstructured":"IDefine [Internet]. [cited 2023 Jan 24]. Kleefstra Syndrome. https:\/\/www.idefine.org\/"},{"key":"3879_CR33","unstructured":"SLC6A1 Connect [Internet]. [cited 2023 Jan 24]. SLC6A1 Connect. https:\/\/slc6a1connect.org\/"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03879-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03879-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03879-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T09:07:16Z","timestamp":1751879236000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03879-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3879"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03879-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"10 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol and all study materials, including the informed consent form and survey used in this study, were approved as required by WCG IRB (study #20190315). All participants provided their informed consent prior to their data being used in this publication, and participant consent forms were archived. Individual-level data were de-identified prior to data analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CAN, EN, MJ, SR, ANC, NDP, and KC were employees of AllStripes Research, Inc. at the time of study execution. CAN, EN, SR, ANC, NDP, and KC held stock options in AllStripes Research, Inc. ANC and KC were employees of and held stock options in PicnicHealth at the time of manuscript editing (PicnicHealth acquired AllStripes\u00a0Research in 2023). CAN has received compensation as a contractor for 23andMe and an honorarium from Global Genes. MJ has received compensation as an employee of Kaiser Permanente Washington and as a contractor for Merck & Co. SR has received honoraria as a member of the ClinGen Adult Actionability Working Group and compensation as an employee of the University of California \u2013 San Francisco. NDP has received compensation as an employee of Exponent, Genentech, and Abbvie.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"344"}}